Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| University of California, San Francisco, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| University of California, San Francisco, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| University of California, San Francisco, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| University of California, San Francisco, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 2 |
| University of California, San Francisco, Medical Devices Deals, 2010 to YTD 2016 | 11 | 1 |
| University of California, San Francisco, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 12 | 3 |
| University of California, San Francisco, Pharmaceuticals &Healthcare, Deal Details | 15 | 42 |
| Partnerships | 15 | 1 |
| Xcell Biosciences Enters into Partnership with University of California, San Francisco | 15 | 1 |
| Selvita Enters into Agreement with University of California, San Francisco | 16 | 1 |
| Natera Enters into Research Agreement with University of California, San Francisco | 17 | 1 |
| UCSF Partners with Berkeley Lights | 18 | 1 |
| BioCision Partners with University of California | 19 | 1 |
| UC San Francisco Enters into Research Agreement with GlaxoSmithKline | 20 | 1 |
| Celgene Partners with Recombinant Antibody Network | 21 | 2 |
| BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture | 23 | 1 |
| Sutro Biopharma Enters into Agreement with University of California, San Francisco | 24 | 1 |
| Daiichi Sankyo Enters Into Co-Development Agreement With Ucsf | 25 | 2 |
| NeoStem Enters Into Agreement With University of California, San Francisco To Develop Human Regulatory T Cells | 27 | 2 |
| Onyx Pharma And UCSF Helen Diller Family Comprehensive Cancer Center Enter Into Co-Development Agreement | 29 | 1 |
| Centers For Therapeutic Innovation Partners with UC San Francisco | 30 | 1 |
| uniQure Enters Into Agreement With University of California, San Francisco To Develop Gene Therapy For Parkinson Disease | 31 | 2 |
| DNAnexus Enters Into Co-Development Agreement With Geisinger Health System And University of California | 33 | 2 |
| University of California Enters Into Research Agreement With Sanofi | 35 | 2 |
| Sanofi-Aventis Enters Into Research Agreement With UCSF | 37 | 2 |
| UCSF Enters Into Co-Development Agreement With Sanofi-Aventis | 39 | 1 |
| Bayer HealthCare Enters Into Research Agreement With University of California | 40 | 1 |
| Bayer Schering Pharma Enters Into Research Agreement With University of California, San Francisco | 41 | 1 |
| UCSF Enters Into Co-Development Agreement With Anacor Pharma And LFKRI Of New York Blood Center | 42 | 2 |
| University of California, San Francisco Enters Into An Agreement With Pfizer | 44 | 2 |
| UCSF Enters Into Drug Discovery Agreement With Genentech | 46 | 1 |
| Licensing Agreements | 47 | 1 |
| Pliant Therapeutics Enters into Licensing Agreement with UC San Francisco | 47 | 1 |
| Optikira Enters into Licensing Agreement with University of California, San Francisco and University of Washington | 48 | 1 |
| SeraCare Life Sciences Enters into Licensing Agreement with University of California | 49 | 1 |
| Calico Life Sciences Enters into Licensing Agreement with University of California, San Francisco | 50 | 1 |
| NeoStem Enters Into Licensing Agreement With University of California, San Francisco | 51 | 2 |
| Carl Zeiss MicroImaging Enters Into Licensing Agreement With University of California, San Francisco | 53 | 1 |
| UCSF Enters Into Licensing Agreement With Zcube | 54 | 1 |
| Stromedix Enters Into Licensing Agreement With University of California, San Francisco | 55 | 1 |
| Celera Enters Into Licensing Agreement With University Of California | 56 | 1 |
| University of California, San Francisco - Key Competitors | 57 | 1 |
| Key Employees | 58 | 2 |
| Locations And Subsidiaries | 60 | 3 |
| Head Office | 60 | 1 |
| Other Locations &Subsidiaries | 60 | 3 |
| Appendix | 63 | 1 |
| Methodology | 63 | 1 |
| About GlobalData | 63 | 1 |
| Contact Us | 63 | 1 |
| Disclaimer | 63 | 1 |